Related Experiment Video
Updated: Sep 12, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Habenular μ-opioid receptor knockout and chronic systemic receptor blockade promote negative affect and heighten
Abstract:
The μ-opioid receptor (MOR), a subtype of opioid G protein-coupled receptor, is expressed in multiple brain circuits and is particularly enriched in the habenula, a small epithalamic structure implicated in aversive states. MOR dysfunction has been linked to several psychiatric and nociceptive disorders. Identifying the key brain regions mediating the behavioral consequences of disrupted MOR signaling can shed light on the role of the opioid system in mood and pain regulation. In this study, we administered methocinnamox (MCAM), a long-acting, pseudo-irreversible MOR antagonist, acutely or chronically to adult C57BL/6J mice. A comprehensive behavioral battery was used to assess affective, social, and pain behavior. A single MCAM administration (10 mg/kg, s.c.) did not alter baseline behavior, but blocked opioid-induced analgesia, suggesting that basal μ-opioid tone does not contribute to these behaviors. In contrast, chronic MCAM administration (10 mg/kg, s.c., 3x/week for 4 weeks) led to increased anxiety-like behavior and decreased sociability, as well as enhanced mechanical allodynia and thermal hyperalgesia. Remarkably, selective knockout of habenular MORs in adult Oprm1fl/fl mice reproduced key features of the chronic MCAM phenotype, including anxiety-like behavior and mechanical hyperalgesia. Together, these findings reveal that sustained inhibition of MOR signaling disrupts affective and nociceptive processing and highlight the habenula as a node mediating key behavioral deficits of disrupted opioid signaling.
Insights
Chronic disruption of the μ-opioid receptor (MOR) signaling in mice increases anxiety, reduces social behavior, and heightens pain sensitivity. The habenula is identified as a key brain region mediating these effects of opioid system dysfunction.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- The μ-opioid receptor (MOR) is crucial for mood and pain regulation, with dysfunction linked to psychiatric and nociceptive disorders.
- The habenula, an epithalamic structure, is rich in MOR and implicated in aversive states.
- Understanding MOR's role in specific brain regions is key to addressing mood and pain disorders.
Purpose of the Study:
- To investigate the behavioral consequences of sustained MOR signaling inhibition.
- To identify key brain regions mediating the effects of disrupted MOR signaling.
- To explore the role of the habenula in affective and nociceptive processing related to opioid signaling.
Main Methods:
- Adult C57BL/6J mice received acute or chronic administration of methocinnamox (MCAM), a MOR antagonist.
- A comprehensive behavioral battery assessed affective, social, and pain behaviors.
- Selective knockout of habenular MORs was performed in adult Oprm1fl/fl mice.
Main Results:
- Chronic MCAM administration induced anxiety-like behavior, decreased sociability, and enhanced mechanical allodynia and thermal hyperalgesia.
- Acute MCAM blocked opioid-induced analgesia but did not alter baseline behavior.
- Selective knockout of habenular MORs replicated key chronic MCAM-induced deficits, including anxiety and mechanical hyperalgesia.
Conclusions:
- Sustained inhibition of MOR signaling disrupts affective and nociceptive processing.
- The habenula is a critical node mediating behavioral deficits associated with disrupted opioid signaling.
- These findings highlight the habenula's importance in mood and pain regulation via the opioid system.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Nociception
Opioid Analgesics: Morphine and Other Natural Cogeners
Pain

